Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Rating) saw a large increase in short interest in August. As of August 15th, there was short interest totalling 2,360,000 shares, an increase of 8.3% from the July 31st total of 2,180,000 shares. Approximately 5.0% of the company's stock are sold short. Based on an average daily trading volume, of 313,800 shares, the days-to-cover ratio is currently 7.5 days.
Aveanna Healthcare Stock Performance
Shares of NASDAQ AVAH traded down $0.06 during trading on Tuesday, hitting $1.91. 779 shares of the company were exchanged, compared to its average volume of 192,351. The firm's fifty day moving average price is $2.24 and its 200 day moving average price is $3.21. Aveanna Healthcare has a 1 year low of $1.89 and a 1 year high of $9.91. The company has a debt-to-equity ratio of 6.19, a current ratio of 0.81 and a quick ratio of 0.81.
Get Aveanna Healthcare alerts:Aveanna Healthcare (NASDAQ:AVAH – Get Rating) last issued its quarterly earnings data on Wednesday, August 10th. The company reported $0.03 EPS for the quarter, missing analysts' consensus estimates of $0.06 by ($0.03). Aveanna Healthcare had a negative net margin of 33.32% and a positive return on equity of 9.57%. During the same quarter last year, the firm earned $0.08 earnings per share. As a group, analysts anticipate that Aveanna Healthcare will post 0.16 EPS for the current year.
Analyst Ratings Changes
A number of analysts have recently weighed in on the company. Stephens cut their price objective on Aveanna Healthcare to $2.75 in a research report on Friday, July 22nd. Credit Suisse Group dropped their target price on shares of Aveanna Healthcare to $5.50 in a research report on Friday, July 22nd. Barclays reduced their price target on shares of Aveanna Healthcare from $7.00 to $5.00 and set an "overweight" rating for the company in a research report on Friday, August 19th. Bank of America lowered Aveanna Healthcare from a "neutral" rating to an "underperform" rating and dropped their price objective for the stock from $3.00 to $2.00 in a report on Tuesday, June 21st. Finally, Jefferies Financial Group downgraded Aveanna Healthcare from a "buy" rating to a "hold" rating and set a $2.50 target price for the company. in a report on Friday, July 22nd. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, five have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, Aveanna Healthcare presently has an average rating of "Moderate Buy" and a consensus price target of $5.33.Institutional Trading of Aveanna Healthcare
A number of hedge funds have recently bought and sold shares of AVAH. Nut Tree Capital Management LP boosted its holdings in shares of Aveanna Healthcare by 40.2% during the fourth quarter. Nut Tree Capital Management LP now owns 5,435,479 shares of the company's stock worth $40,223,000 after purchasing an additional 1,557,591 shares during the last quarter. Westwood Holdings Group Inc. boosted its stake in Aveanna Healthcare by 24.9% in the 4th quarter. Westwood Holdings Group Inc. now owns 4,163,789 shares of the company's stock worth $30,812,000 after buying an additional 829,270 shares during the last quarter. Littlejohn & Co. LLC grew its holdings in Aveanna Healthcare by 12.4% in the 2nd quarter. Littlejohn & Co. LLC now owns 3,895,001 shares of the company's stock valued at $8,803,000 after buying an additional 429,900 shares during the period. Principal Financial Group Inc. increased its stake in shares of Aveanna Healthcare by 27.7% during the 2nd quarter. Principal Financial Group Inc. now owns 3,137,855 shares of the company's stock valued at $7,091,000 after acquiring an additional 680,016 shares during the last quarter. Finally, BlackRock Inc. lifted its holdings in shares of Aveanna Healthcare by 2.3% during the 1st quarter. BlackRock Inc. now owns 3,087,209 shares of the company's stock worth $10,526,000 after acquiring an additional 69,609 shares during the period. Institutional investors and hedge funds own 92.00% of the company's stock.
About Aveanna Healthcare
(Get Rating)
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals.
Read More
- Get a free copy of the StockNews.com research report on Aveanna Healthcare (AVAH)
- Shock Absorbers: 3 Low Volatility Dividend Stocks for Bumpy Times
- The Retail Sector: Winners And Losers From Q2 Earnings
- Can Targa Continue Rallying To Meet Its Price Target?
- Is Unity Software Ready To Rally After Rejecting AppLovin Offer?
- MarketBeat Podcast: The Time For Cloud Stocks May Be Now
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.